The committee will convene a public workshop and closed session meetings on the dates and times listed below. The public workshop will be held at the American Public Health Association, 800 I (Eye) Street, NW, Washington, DC 20001. 

Committee on Perspectives on the role of Intermittent Preventive Treatment for Malaria in Infants (IPTi)

Open Sessions of the Committee Meeting Agenda, January 9 – 10, 2008

Location: American Public Health Association
800 I (Eye) Street, NW; Washington DC, 20001-3710
) 202-77 (Ph) 202-777-APHA7-APHAMain Conference Room A, 1st Floor
Phone Number: (202) 777-APHA

Meeting Goal for Open portions of the meeting:
Invited presentations to the committee from various experts on aspects of IPTi or other issues relevant to topic to aid in the committee’s deliberations.

DAY 1: Wednesday, January 9, 2008
APHA Conference Room A

10:00am – 10:30am Welcoming Remarks
Speakers: Patrick Kelley, MD, DrPH
Director, Board on Global Health, IOM
Mike Levine, MD, DTPH
Director, Center for Vaccine Development,
University of Maryland School of Medicine

10:30am – 11:00am Remarks from Sponsor

Speaker: David Brandling-Bennett, MD, DTPH
Project Officer, Bill & Melinda Gates Foundation

11:00am – 11:20am Antimalarial drugs and drug resistance

Speaker: Christopher Plowe, MD, MPH
Center for Vaccine Development’s Malaria Section
University of Maryland, and IOM Committee Member
 

11:20am - 11:40am Malaria overview and burden of malaria in infancy

Miriam Laufer, MD, MPH
Assistant Professor of Pediatrics
Center for Vaccine Development
University of Maryland School of Medicine
IOM Committee Member

11:40am – 12:15pm Childhood Immunizations/EPI in Developing Country Context

Speaker: Neal Halsey, MD, MPH
Professor, Department of International Health,
Johns Hopkins Bloomberg School of Public Health
IOM Committee Member

12:15pm – 1:00pm Lunch (provided)

1:00pm – 1:45pm Overview of IPTi Consortium; Policy process

Speakers: Andrea Egan, PhD
Coordinator, IPTi Consortium

Pedro Alonso, MD, PhD
Director, Barcelona Centre for International Health
Research at the Hospital Clinic and Professor at the
University of Barcelona

1:45pm – 2:15pm Pooled efficacy of Intermittent Preventive Treatment for Malaria in Infants with Sulphadoxine-Pyrimethamine (IPTi-SP)

Speaker: John Aponte, MD, MSc
Head, Statistics Unit of the Barcelona Centre for
International Health Research (CRESIB)

2:15pm – 2:30pm Break

2:30pm – 4:30pm Acceptability, Cost effectiveness, Drug resistance, Applicability of IPTi –SP, Effectiveness study of IPTi-SP

Speaker: David Schellenberg, MBBS, DTMH, MRCP, PhD
Professor, Malaria and International Health
London School of Hygiene and Tropical Medicine

World Health Organisation’s Global Malaria Program: Considerations of IPTi-SP within context of malaria control program

Speaker: Dr. Peter Olumese, M.B., FMCPaed
Case Management and Research Team, Global
Malaria Programme, World Health Organisation

4:30pm – 5:15pm United Nations Children’s Fund (UNICEF) Pilot
Implementation of IPTi-SP

Speaker: Alexandra de Sousa, MD, PhD
Operational Research Coordinator
Unit of Policy and Evidence, UNICEF

5:15pm – 5:30pm Concluding remarks/Questions

Speaker: Mike Levine, MD, DTPH
 

DAY 2: Thursday, January 10, 2008
APHA Conference Room A

9:00am – 10:15am
Pooled safety of IPTi-SP

Speaker: Sir Alasdair Breckenridge, MD, MSc
Chairman, UK Medicines and Healthcare Products
Regulatory Agency

Potential impact of IPT on spread of drug resistant malaria:
Considerations from mathematical modeling

Speaker: Wendy Prudhomme O’Meara, PhD
Research Associate NIH/Fogarty Center,
Centre for Geographic Medicine Research, KEMRI-
Wellcome Trust Research Center

10:15am – 10:30am Break

10:30am – 11:30am Program Implementation Challenges in a Developing Country Context

Speaker: Carol Medlin, PhD, MPA
Professor, Anthropology and Social Medicine
University of California, San Francisco

11:30am – 12:00pm Kisumu - Results from first trial of IPTi with alternative drugs to Sulphadoxine-Pyrimethamine

Speaker: Larry Slutsker, MD, MPH
Chief, Malaria Branch of the U.S. Centers for Disease Control and Prevention

12:00pm – 2:00pm CLOSED LUNCH SESSION for Committee, Conference
Room C (provided)

12:00pm – 2:00pm Lunch for Speakers and Registered Guests in Conference Room A (provided)

2:00pm Resumption of Open Sessions

2:15pm –2:45pm Considerations for the Implementation of IPTi (by phone)

Speaker: Brian Greenwood, MD
Manson Professor of Clinical Tropical Medicine
Department of Infectious and Tropical Diseases
London School of Hygiene and Tropical Medicine

Public comment session will be held at the conclusion of the call with Dr. Greenwood.

No later than 4:00pm Concluding Remarks and Adjournment to Closed Sessions

Speakers: Mike Levine, MD, DTPH
IOM Committee Chair

Pat Kelley, MD, DrPH
Director, IOM Board on Global Health

DAY 3:  Committee Meeting:  8:30pm – 5:00pm (Closed to the Public)